Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1975]
News [3813]
Articles [100]
Editorials [5]
Conferences [165]
elearning [19]
Examining NSCLC responses to durvalumab monotherapy
Brandon Higgs - MedImmune, Gaithersburg, USA
Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )
1 Oct 2015
ECC 2015 scientific highlights
Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015
Atezolizumab limits disease progression for metastatic urothelial bladder cancer
Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Sep 2015
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC
Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )
30 Sep 2015
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise
Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015
Multi-peptide vaccine for kidney cancer fails to improve survival
Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA
Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )
28 Sep 2015
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC
Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015
Latest in lung cancer from ECC 2015
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015
COMBI-V: Melanoma survival improved by targeted drug combination
Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France
COMBI-V: Melanoma survival improved by targeted drug combination ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )
28 Sep 2015
Prostate highlights from ECC 2015
Prof Noel Clarke and Dr Bertrand Tombal
Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )
27 Sep 2015
Melanoma immunotherapy latest and TVEC plus pembrolizumab
Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015
Comment: New immunotherapy options for kidney cancer
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation